Patients with castration-resistant prostate cancer (CRPC) with bone metastasis also showed less ALKBH5 downregulation compared to patients with CRPC with lymph node metastasis. The gene discussed is ALKBH5; the disease is metastatic malignant neoplasm in the lymph nodes.